Prot #GR40398: A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of RO6867461 in Patients with Diabetic Macular Edema (Rhine)

Project: Research project

Project Details

StatusFinished
Effective start/end date12/18/18 → 2/1/22

Funding

  • Syneos Health, Inc. (Prot #GR40398)
  • Genentech, Inc. (Prot #GR40398)